Literature DB >> 33194195

Deep vein thrombosis of the upper extremity caused by central venous port in a patient with soft tissue sarcoma: A case report.

Kouji Kita1, Tomoki Nakamura1, Kouichi Nakamura1, Tomohito Hagi1, Kunihiro Asanuma1, Akihiro Sudo1.   

Abstract

Deep vein thrombosis (DVT) more commonly occurs in the lower extremities, whereas involvement of the upper extremities is rare. The present case report describes the clinical course of the development and treatment of upper extremity DVT (UEDVT) following insertion of an indwelling central venous (CV) port in a patient with soft tissue sarcoma (STS) of the thigh. A 66-year-old man was referred to our hospital for STS treatment. The indwelling CV port was placed via the left subclavian vein, and two courses of neoadjuvant chemotherapy were administered. Two months after the catheter placement, DVT was detected from the left upper arm to the left internal jugular vein. Anticoagulation therapy with warfarin was started and DVT was undetectable at 5 months after surgery. In conclusion, DVT may occur in cancer patients who undergo treatment with indwelling CV ports. Therefore, screening should be conducted concurrently with surgical resection and chemotherapy for STS.
Copyright © 2020, Spandidos Publications.

Entities:  

Keywords:  central venous port; deep vein thrombosis; upper extremity

Year:  2020        PMID: 33194195      PMCID: PMC7657082          DOI: 10.3892/mco.2020.2160

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  10 in total

1.  Upper-extremity deep vein thrombosis: a prospective registry of 592 patients.

Authors:  Hylton V Joffe; Nils Kucher; Victor F Tapson; Samuel Z Goldhaber
Journal:  Circulation       Date:  2004-09-07       Impact factor: 29.690

2.  Catheter-related venous thrombosis.

Authors:  Natalie S Evans; Elizabeth V Ratchford
Journal:  Vasc Med       Date:  2018-06-28       Impact factor: 3.239

3.  Spectrum of upper-extremity deep venous thrombosis in a community teaching hospital.

Authors:  M A Marinella; S K Kathula; R J Markert
Journal:  Heart Lung       Date:  2000 Mar-Apr       Impact factor: 2.210

Review 4.  Cancer-associated venous thromboembolism: Burden, mechanisms, and management.

Authors:  Cihan Ay; Ingrid Pabinger; Alexander T Cohen
Journal:  Thromb Haemost       Date:  2016-11-24       Impact factor: 5.249

5.  Upper-extremity deep vein thrombosis related to central venous port systems implanted in cancer patients.

Authors:  S Yukisawa; Y Fujiwara; Y Yamamoto; T Ueno; K Matsueda; A Kohno; M Suenaga
Journal:  Br J Radiol       Date:  2010-03-11       Impact factor: 3.039

Review 6.  Venous thromboembolism associated with long-term use of central venous catheters in cancer patients.

Authors:  Melina Verso; Giancarlo Agnelli
Journal:  J Clin Oncol       Date:  2003-10-01       Impact factor: 44.544

Review 7.  Venous access catheter-related thrombosis in patients with cancer.

Authors:  Manila Gaddh; Ana Antun; Kei Yamada; Pooja Gupta; Ha Tran; Fuad El Rassi; Hyun S Kim; Hanna Jean Khoury
Journal:  Leuk Lymphoma       Date:  2013-07-12

8.  Characterizing resolution of catheter-associated upper extremity deep venous thrombosis.

Authors:  Mark A Jones; Dae Y Lee; Jocelyn A Segall; Gregory J Landry; Timothy K Liem; Erica L Mitchell; Gregory L Moneta
Journal:  J Vasc Surg       Date:  2009-10-30       Impact factor: 4.268

9.  Preoperative and postoperative chemotherapy with ifosfamide and adriamycin for adult high-grade soft-tissue sarcomas in the extremities: Japan Clinical Oncology Group Study JCOG0304.

Authors:  Kazuhiro Tanaka; Hiroshi Kawamoto; Isamu Saito; Kenichi Yoshimura; Haruhiko Fukuda; Yukihide Iwamoto
Journal:  Jpn J Clin Oncol       Date:  2009-01-20       Impact factor: 3.019

10.  A STROBE cohort study of 755 deep and superficial upper-extremity vein thrombosis.

Authors:  Gaetan Ploton; Marc-Antoine Pistorius; Alizée Raimbeau; Julien Denis Le Seve; Guillaume Bergère; Chan Ngohou; Yann Goueffic; Mathieu Artifoni; Cécile Durant; Giovanni Gautier; Jérôme Connault; Olivier Espitia
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.